There are still a wide range of discoveries to be made within the field, from further elucidating the role of MYC in affecting the circadian clock of cells in the tumor microenvironment to establishing the clinical value of MYC inhibition and further developing methods to assess patient circadian rhythms. The gene discussed is MYC; the disease is neoplasm.